ReviewInternational journal of molecular sciences2026
Zebrafish Models of Parkinson's Disease: From Pathogenesis to Drug Discovery.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the aggregation of Lewy bodies, composed of the protein α-synuclein, and the degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta. The management of PD seeks to mitigate motor symptoms by substituting diminished endogenous dopamine; nevertheless, it does not halt disease progression. Various animal models have been employed to elucidate the etiology of PD and to discover disease-modifying treatments. Zebrafish serve as a PD model owing to their capacity for high-throughput screening. This review presents updates on the currently available zebrafish models of PD, encompassing both chemically induced and genetically based models, and discusses their advantages and limitations. This review also delineates numerous investigative strategies that utilize the zebrafish PD model and summarizes the findings of previous studies. Taken together, further studies, including the investigation of the regeneration mechanism of DA neurons, neurobehavioral testing of adult zebrafish reflecting PD-associated neurocognitive impairment, and a reliable gene-based model providing precise gene knockout and reproducibility, may assist in elucidating the critical pathways that trigger PD and its progression, alongside potential targets to hinder this progression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.